Antiemetics Drugs Market Size To Reach $11.20 Billion By 2030

Antiemetics Drugs Market Growth & Trends

The global antiemetics drugs market size is expected to reach USD 11.20 billion by 2030, exhibiting a CAGR of 5.98% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as the increasing strategic initiatives of the key players coupled with the increasing prevalence of various diseases causing nausea and vomiting are propelling market demand forward.

The rising activity of major industry players is one of the major factors bolstering the demand for antiemetics drugs. Industry participants are undertaking various initiatives such as partnerships, acquisitions, new product launches, product approvals, and expansions to strengthen their position in the antiemetics drugs market. For instance, in May 2020, the U.S. Food and Drug Administration approved an AKYNZEO injection from the Helsinn Group for the prevention of nausea and vomiting induced by chemotherapy. Thus, increasing novel product approvals are anticipated to drive industry growth in the coming years.

In addition to key indications such as chemotherapy and postoperative nausea and vomiting (PONV), other conditions such as food poisoning and alcohol consumption are also driving the demand for these medicines over the forecast period. An article published by NCBI in November 2021 suggests that certain over-the-counter antiemetics, such as Bismuth Subsalicylate, are effective in addressing nausea and vomiting associated with food poisoning.

Moreover, a study published in Frontiers in October 2022 reported that ondansetron, a serotonin receptor antagonist, is an effective treatment for alcohol use disorder in patients with early onset alcoholism (EOA). Consequently, the demand for antiemetic medicines is expected to rise in response to increased alcohol consumption and incidents of food poisoning.

 Request a free sample copy or view report summary: Antiemetics Drugs Market Report

Antiemetics Drugs Market Report Highlights

• On the basis of drug type, the serotonin-receptor antagonists segment dominated the market at 29.71% in 2023 and this dominance can be attributed to the rising cases of cancer coupled with the increasing use of serotonin-receptor antagonist drugs.

• Based on the application, the chemotherapy segment was the largest revenue contributor to the market with a share of 45.70% in 2023 owing to the increasing product launches targeting nausea and vomiting associated with chemotherapy.

• In the end-use segment, the retail pharmacy segment dominated the market with a revenue share of 47.91% in 2023. In contrast, the other segment is anticipated to register the fastest growth over the forecast period.

• The North America region dominated the market with a share of 36.52% in 2023 owing to the presence of major players like Pfizer, Merck Co & Inc, and GSK plc. On the other hand, Asia Pacific is expected to showcase the fastest growth over the forecast period.

Antiemetics Drugs Market Segmentation

Grand View Research has segmented the global antiemetics drugs market based on drug type, application, end-use, and region:

Antiemetics Drug Type Outlook (Revenue, USD Million, 2018 - 2030)

• Serotonin-receptor Antagonists

• Anticholinergics

• Dopamine Receptor Antagonists

• Neurokinin Receptor Antagonists

• Others (Antihistamines, Cannabinoids)

Antiemetics Drugs Application Outlook (Revenue, USD Million, 2018 - 2030)

• Chemotherapy

• Gastroenteritis

• Post Operative Surgery

• Others (Vertigo, Motion Sickness)

Antiemetics Drugs End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital & Clinics

• Retail Pharmacy

• Others

Antiemetics Drugs Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Antiemetics Drugs Market

• Pfizer Inc.

• Cipla Inc.

• Merck KGaA

• Eagle Pharmaceuticals, Inc.

• Johnson & Johnson Services, Inc.

• GSK plc.

• Astellas Pharma Inc.

• GLENMARK PHARMACEUTICALS LTD.

• Viatris Inc.

• Baxter